Clinical Trials Logo
  1. Home
  2. Renal Dialysis
  3. NCT06376968

Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis

Renal Dialysis Clinical Trial

Official title:
Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis

Clinical Trial Summary

The goal of this prospective, randomized, controlled, cross-over, multicentric study is to demonstrate the safety of bioLogic Fusion in patients on chronic haemodialysis or hemodiafiltration prone to hypotensive episodes. The main question it aims to answer is: • Which is the number and percentage of individual sessions with reached prescribed post-dialysis body weight in the prescribed treatment time in each single session in hypotensive-prone patients on high-flux haemodialysis or hemodiafiltration within each patient with treatments performed with DialogiQ with (treatment A) or without (treatment B) the bioLogic Fusion option activated? Participants will in addition to their routine dialysis treatment undergo 2 physical examinations and regularly answer questionnaires. A crossover design is used to compare treatments with or without the BioLogic Fusion function activated.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06376968
Study type Interventional
Source B.Braun Avitum AG
Contact Strube Frank
Phone +4915257240618
Email frank.strube@bbraun.com
Status Recruiting
Phase N/A
Start date April 22, 2024
Completion date August 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT05189795 - The Construction of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
Completed NCT01125202 - Intervention to Reduce Dietary Sodium in Hemodialysis N/A
Completed NCT00806130 - Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients
Completed NCT00753116 - Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension Phase 1
Completed NCT00730145 - A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis Phase 1
Completed NCT05718765 - The Effect of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients N/A
Completed NCT03250715 - Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure N/A
Completed NCT05469620 - Adaptive Nutrition Therapy in Hemodialysis N/A
Completed NCT03536858 - Social Networks and Renal Education: Promoting Transplantation N/A
Completed NCT00824837 - Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane Phase 1/Phase 2
Completed NCT03403491 - Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis N/A
Terminated NCT02495662 - The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation Phase 2
Completed NCT01179620 - Certoparin in Renal Patients Undergoing Hemodialysis Phase 3
Completed NCT01017276 - A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis Phase 3
Active, not recruiting NCT04466865 - A Communication Tool to Assist Older Adults Facing Dialysis Choices N/A
Recruiting NCT03782519 - Quality of Life of Frail Aged Patients in Incremental Hemodialysis N/A
Recruiting NCT02843334 - Study of the Prevalence of Fabry Disease in French Dialysis Patients N/A
Recruiting NCT02545530 - Transdermal Clonidine in Chronic Hemodialysis Patients N/A
Completed NCT00892749 - Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis Phase 3
Completed NCT00649298 - A Clinical Trial of IntensiVE Dialysis Phase 4